ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $515,797 | -70.9% | 19,196 | -61.4% | 0.00% | -80.0% |
Q2 2023 | $1,773,514 | -63.8% | 49,734 | -74.2% | 0.01% | -75.0% |
Q1 2023 | $4,894,224 | +1843.4% | 192,686 | +3003.3% | 0.02% | +1900.0% |
Q4 2022 | $251,837 | +5.4% | 6,209 | -14.0% | 0.00% | 0.0% |
Q3 2022 | $239,000 | -95.0% | 7,223 | -94.7% | 0.00% | -96.3% |
Q2 2022 | $4,799,000 | +427.4% | 136,295 | +588.6% | 0.03% | +575.0% |
Q1 2022 | $910,000 | +109.2% | 19,793 | +184.3% | 0.00% | +300.0% |
Q3 2021 | $435,000 | -15.7% | 6,961 | +11.8% | 0.00% | -50.0% |
Q2 2021 | $516,000 | -43.3% | 6,229 | -70.5% | 0.00% | -83.3% |
Q3 2020 | $910,000 | -16.0% | 21,134 | -15.7% | 0.01% | -33.3% |
Q2 2020 | $1,083,000 | -44.7% | 25,072 | -63.1% | 0.02% | -64.0% |
Q1 2020 | $1,957,000 | +353.0% | 68,020 | +898.7% | 0.05% | +1566.7% |
Q4 2019 | $432,000 | +14.6% | 6,811 | -49.1% | 0.00% | 0.0% |
Q3 2019 | $377,000 | -36.9% | 13,385 | -40.5% | 0.00% | -50.0% |
Q2 2019 | $597,000 | -64.1% | 22,510 | -75.2% | 0.01% | -66.7% |
Q1 2019 | $1,664,000 | +740.4% | 90,654 | +468.4% | 0.02% | +800.0% |
Q4 2018 | $198,000 | +5.3% | 15,949 | -68.8% | 0.00% | -33.3% |
Q4 2017 | $188,000 | +164.8% | 51,200 | +212.2% | 0.00% | +200.0% |
Q3 2017 | $71,000 | +44.9% | 16,400 | -46.0% | 0.00% | 0.0% |
Q2 2017 | $49,000 | +63.3% | 30,398 | +57.2% | 0.00% | 0.0% |
Q4 2016 | $30,000 | – | 19,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |